GD2 targeting CAR T cells for neuroblastoma
Treatment of neuroblastoma is a significant clinical unmet need in paediatric oncology epitomised by high-risk disease in which relapse is common and outcomes for children with relapse or primary refractory disease are typically poor, with 4-year progression-free survival for relapse/refractory dise...
Saved in:
| Main Authors: | John Anderson, Giuseppe Barone, Alexandra Zehner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | EJC Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X24000382 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FUNCTIONAL ACTIVITY OF ANTI-GD2 CAR-T CELLS WITH DIFFERENT ANTIGEN-RECOGNITION MODULE
by: Dzmitry Lutskovich, et al.
Published: (2019-08-01) -
Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma
by: Francesca De Mitri, et al.
Published: (2025-07-01) -
The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1
by: Adeiye A. Pilgrim, et al.
Published: (2023-12-01) -
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells
by: Michele Pezzella, et al.
Published: (2024-12-01) -
Near-infrared photoimmunotherapy using antiGD2 antibody for neuroblastoma and osteosarcoma
by: Jimei Zhao, et al.
Published: (2025-06-01)